RCS - EKF Diagnostics Hldg - Point-of-Care update

EKF Diagnostics HoldingsAnnouncement

22/12/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221222:nRSV5401Ka&default-theme=true

RNS Number : 5401K  EKF Diagnostics Holdings PLC  22 December 2022

 

RNS Reach

EKF Diagnostics Holdings plc

("EKF", the "Company" or the "Group")

 

Point-of-Care update

Further innovation across established business

 

Launch of hand-held lactate analyser for the veterinary market

following earlier launch of updated hand-held haemoglobin analyzer with EKF
Link digital connectivity

 

EKF Diagnostics Holdings plc (AIM: EKF), the AIM-listed global diagnostics
business, announces further product innovation in its established
Point-of-Care ("POC") business with the launch of Lactate Scout Vet
(https://www.ekfdiagnostics.com/lactate-scout-vet1.html) , a hand-held lactate
analyzer designed specifically for POC testing in veterinary settings. This
follows the launch of EKF's enhanced version of DiaSpect Tm
(https://www.ekfdiagnostics.com/diaspect.html) , in October 2022, with
wireless connectivity powered by the newly released EKF Link middleware
(https://www.ekfdiagnostics.com/ekf-launches-poc-connectivity-solution.html) ,
which allows POC test results to be centralised in one place and enables
real-time remote management of data.

 

Lactate Scout Vet

Lactate Scout Vet uses the same proven technology that was initially developed
to provide elite sports coaches and athletes with a precise and easy-to-use
hand-held lactate test. Lactate Scout Vet has the ability to deliver accurate
lactate measurements within 10 seconds, from just a 0.2 µL capillary blood
sample, taken via earlobe prick. It has quick and easy species selection
options and can store up to 500 results. Lactate Scout Vet is a user-friendly
device, and the simple to navigate e-paper display provides excellent
readability in varying light conditions, as well as at different viewing
angles.

 

Lactate testing is increasingly used in the veterinary clinic for prognosis
and diagnosis in a number of clinical presentations. It can be applied as a
rapid triage and risk stratification tool assigning higher and lower risk
categories. EKF's new Lactate Scout Vet provides validated results comparable
to laboratory-based testing, allowing the veterinarian to obtain rapid,
reliable results at the POC and also helps to inform treatment decisions,
while providing the opportunity to monitor whole blood lactate concentration
in real-time.

 

DiaSpect Tm launched with secure POC connectivity

In October 2022, EKF launched a new version of DiaSpect Tm, now powered by EKF
Link, enabling new functions like Hematocrit calculation, quality control
management and patient data management functions. DiaSpect Tm delivers
laboratory quality results in one second from the microcuvette being placed
into the analyzer.

 

The haemoglobin analyzer is palm-sized, making it easily transportable, and
ideal for use in any screening setting even in challenging climatic
environments, and is now compatible with the new state-of-the-art POC data
management platform.

 

Mike Salter, CEO, of EKF, said: "With our vast experience in lactate
measurement in the clinical diagnostics market, we are excited to launch our
latest analyzer, Lactate Scout Vet, which is designed specifically for the
veterinary market. We are already a well-established manufacturer, supplier,
distributor and exporter globally of lactate analyzers, delivering dependable
pre and post-sales support. We pride ourselves on developing easy-to-use
devices that provide reliable, fast and accurate results."

 

"Just a few weeks ago, our team successfully introduced our POC testing
connectivity solutions at MEDICA trade conference, including the enhanced
DiaSpect Tm hand-held haemoglobin analyser and the new EKF Link digital
connectivity software, both of which were well received. It is great to see
that we continue to make further progress on new product and new market
initiatives."

 

 

 

 

 

 

EKF's Lactate Scout Vet hand-held analyzer

 

 

DiaSpect Tm powered by EKF Link - a hand-held hemoglobin analyzer

 

 EKF Diagnostics Holdings plc                   www.ekfdiagnostics.com (http://www.ekfdiagnostics.com)
 Mike Salter, CEO                                Tel: +44 (0)29 2071 0570
 Marc Davies, CFO

 Singer Capital Markets (Nominated Adviser & Joint Broker)                               Tel: +44 (0)20 7496 3000
 Aubrey Powell / George Tzimas / Oliver Platts

 Investec Bank plc (Joint Broker)               Tel: +44 (0)20 7597 4000
 Gary Clarence / Daniel Adams / Ben Farrow

 Walbrook PR Limited                            Tel: +44 (0)20 7933 8780 or ekf@walbrookpr.com (mailto:ekf@walbrookpr.com)
 Paul McManus / Lianne Applegarth               Mob: +44 (0)7980 541 893 / +44 (0)7584 391 303

 

About EKF Diagnostics Holdings plc (www.ekfdiagnostics.com
(http://www.ekfdiagnostics.com) )

EKF is a leading global diagnostics business with custom manufacturing
facilities across sites in the US, UK and Europe for a variety of life science
products. EKF is focussed on the following areas:

 

 Point-of-Care           Providing a portfolio of Point-of-Care analysers and consumables, particularly
                         for use in the area of Hematology and Diabetes, for use in hospital and
                         research laboratories, doctor's offices, blood banks and anaemia screening
                         programmes. EKF has an estimated 80,000 hemoglobin, hematocrit, HbA1c, glucose
                         and lactate analysers in regular use across more than 100 countries.

 Central Laboratory      Clinical chemistry, small lab analysers

                         Beta-Hydroxybutyrate (β-HB) LiquiColor, Glycated Albumin

 Life Sciences           Small and large-scale enzyme fermentation, custom and contract manufactured
                         products
 Contract Manufacturing  Bulk formulation, sample collection kits, private labelling, molecular and
                         forensic kits

 Laboratory Testing      Laboratory testing services certified under the Clinical Laboratory
                         Improvement Amendments ("CLIA") for high complexity testing

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRATBBPTMTATBFT